FR2369841A1 - Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur - Google Patents

Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur

Info

Publication number
FR2369841A1
FR2369841A1 FR7733216A FR7733216A FR2369841A1 FR 2369841 A1 FR2369841 A1 FR 2369841A1 FR 7733216 A FR7733216 A FR 7733216A FR 7733216 A FR7733216 A FR 7733216A FR 2369841 A1 FR2369841 A1 FR 2369841A1
Authority
FR
France
Prior art keywords
benzodiazepine
minor
cardiovascular system
opt
tranquilliser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7733216A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2369841A1 publication Critical patent/FR2369841A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des préparations pharmaceutiques nouvelles. Il s'agit de préparations pharmaceutiques qui contiennent comme principes pharmacologiquement actifs le 1-(o-allyloxyphénoxy)-3-isopropylamino-2-propanol ou le 1-Øp-(2-méthoxyéthyl)-phénoxyõ-3-isopropylamino-2-propanol ou un sel de ce corps utilisable en pharmacie et un dérivé benzodiazépinique actif comme << tranquillisant mineur >>. Ces compositions sont utiles pour le traitement des états d'anxiété.
FR7733216A 1976-11-08 1977-11-04 Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur Withdrawn FR2369841A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (fr) 1976-11-08 1976-11-08

Publications (1)

Publication Number Publication Date
FR2369841A1 true FR2369841A1 (fr) 1978-06-02

Family

ID=19728406

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7733216A Withdrawn FR2369841A1 (fr) 1976-11-08 1977-11-04 Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur

Country Status (9)

Country Link
JP (1) JPS5359035A (fr)
AU (1) AU3041877A (fr)
BE (1) BE860526A (fr)
DE (1) DE2749318A1 (fr)
FR (1) FR2369841A1 (fr)
IL (1) IL53318A0 (fr)
LU (1) LU76150A1 (fr)
NL (1) NL7712100A (fr)
ZA (1) ZA776645B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168044A2 (fr) * 1984-07-12 1986-01-15 Fujisawa Pharmaceutical Co., Ltd. Comprimé à effet retard

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042334A1 (fr) * 1969-04-16 1971-02-12 Boehringer Sohn Ingelheim

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042334A1 (fr) * 1969-04-16 1971-02-12 Boehringer Sohn Ingelheim

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168044A2 (fr) * 1984-07-12 1986-01-15 Fujisawa Pharmaceutical Co., Ltd. Comprimé à effet retard
EP0168044A3 (en) * 1984-07-12 1987-04-15 Fujisawa Pharmaceutical Co., Ltd. Sustained release tablet

Also Published As

Publication number Publication date
NL7712100A (nl) 1978-05-10
AU3041877A (en) 1979-05-17
IL53318A0 (en) 1978-01-31
ZA776645B (en) 1978-08-30
JPS5359035A (en) 1978-05-27
BE860526A (fr) 1978-05-08
DE2749318A1 (de) 1978-05-11
LU76150A1 (fr) 1978-07-10

Similar Documents

Publication Publication Date Title
NO161257C (no) Analogifremgangsm te for fremstilling av antiviralt aktive pyridazinaminer.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2&#39;-iminobisetanol.
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE82968T1 (de) Hemmung vom 5-lipoxygenase-weg.
GR3023281T3 (en) Rapidly disintegratable multiparticulate tablet
ATE41739T1 (de) Feste orale dosierungsformulierungen von kardiovaskularen heilmitteln mit konstanter freisetzungsgeschwindigkeit.
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
CA2125888A1 (fr) Composition contenant un antioxydant pharmaceutiquement actif et son utilisation dans la prevention et le traitement de la restenose post-angioplastie
RU93004484A (ru) Производные пиразола, способ их получения и содержащие их фармацевтические композиции
ES2090317T3 (es) Uso del acido 3-guanidinopropionico en la fabricacion de un medicamento para el tratamiento y prevencion del exceso de adiposidad.
ZA88642B (en) 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine,various derivatives thereof,processes for the preparation of these compounds,medicaments containing them,and their use
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
FR2369841A1 (fr) Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur
IT1252185B (it) Preparazioni farmaceutiche a liberazione programmata
ES473534A1 (es) Procedimiento para la preparacion de analogos de prostaci- clina
HUT46337A (en) Process for producing n-(2-/2-hydroxy-3-phenoxy-propyl/-aminoethyl)-isobutyramide and pharmaceutical compositions comprising such active ingredient
JPS5536453A (en) Novel immunosuppressive agent
GB1500666A (en) Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them
JPS52148042A (en) New derivative of 33*3*55dichlorophenyl**ureido acetic acid and process for manufacture thereof and germicide containing said derivative as active ingredient
JPS5246067A (en) Reduction of optically active 5-oxo-2-pyrrolidinacetic acid esters
HU179068B (en) Herbicide compositions containing esters of carbanilidic acid derivatives and process for producing the active agents
ATE26399T1 (de) Synergetische antiphlogistische zusammensetzungen und verfahren zu ihrer herstellung.
HUT38834A (en) Process for preparing cosmetic compositions against pimples and comedos
FR1271960A (fr) Procédé pour la préparation de composés aliphatiques non satures, notamment d&#39;acides et de leurs esters

Legal Events

Date Code Title Description
ST Notification of lapse